Currently, polymerase chain reaction, a DNA-based test, is used for detecting CRE, which are known for their ability to resist major antibiotics. However, these types of tests are expensive and require a lot of equipment.
The new test, known as Carba NP, is less expensive and takes just hours to produce results.
The Oregon State Public Health Lab researchers evaluated the ability of Carba NP to identify clinical isolates as carbapenemase producers. They achieved 100 percent sensitivity.
“We conclude that the Carba NP test is highly sensitive, specific and reproducible for the detection of carbapenemase production in a diverse group of organisms,” said Karim Morey of the Oregon State Public Health Lab.
More articles on infection control:
What insect’s bacteria could replace antibiotics?
Rare respiratory virus sweeping through US: What healthcare providers need to know
A new soldier in the war against HAIs: UV robots
